Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech สหภาพยุโรป - เอสโตเนีย - EMA (European Medicines Agency)

human igg1 monoclonal antibody specific for human interleukin-1 alpha xbiotech

xbiotech germany gmbh - inimese iggl monoklonaalne antikeha, mis on spetsiifiline inimese interleukiin-1 alfa suhtes - kolorektaalne kasvaja - antineoplastilised ained - ravi metastaatilise kolorektaalse vähi.

Comirnaty สหภาพยุโรป - เอสโตเนีย - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.

FINASTERIDE TEVA õhukese polümeerikattega tablett เอสโตเนีย - เอสโตเนีย - Ravimiamet

finasteride teva õhukese polümeerikattega tablett

teva pharma b.v. - finasteriid - õhukese polümeerikattega tablett - 5mg 84tk; 5mg 56tk; 5mg 50tk; 5mg 98tk; 5mg 15tk; 5mg 20tk; 5mg 28tk; 5mg 14tk; 5mg 120tk

PEG L-ASPATERO süste-/infusioonilahus เอสโตเนีย - เอสโตเนีย - Ravimiamet

peg l-aspatero süste-/infusioonilahus

virchow biothech pvt ltd - pegaspargaas - süste-/infusioonilahus - 750rÜ 1ml 5ml 1tk

DIPHTHERIA ANTITOXIN I.P süstelahus เอสโตเนีย - เอสโตเนีย - Ravimiamet

diphtheria antitoxin i.p süstelahus

virchow biothech pvt ltd - difteeria antitoksiin - süstelahus - 1000rÜ 1ml 10ml 1tk

Rabitec สหภาพยุโรป - เอสโตเนีย - EMA (European Medicines Agency)

rabitec

ceva santé animale - nõrgestatud elusate marutaudivastaste vaktsiinide viirus, tüvi spbn gasgas - immunoloogilised ravimid jaoks canidae, live viral vaccines - red foxes (vulpes vulpes); raccoon dogs (nyctereutes procyonoides) - rebase ja marutaudi aktiivseks immuniseerimiseks marutaudi vastu, et ennetada nakatumist ja suremust.

ANDROFIN õhukese polümeerikattega tablett เอสโตเนีย - เอสโตเนีย - Ravimiamet

androfin õhukese polümeerikattega tablett

g.l. pharma gmbh - finasteriid - õhukese polümeerikattega tablett - 5mg 14tk; 5mg 90tk; 5mg 15tk; 5mg 20tk; 5mg 10tk; 5mg 30tk; 5mg 50tk; 5mg 100tk

FINPROS 5 MG õhukese polümeerikattega tablett เอสโตเนีย - เอสโตเนีย - Ravimiamet

finpros 5 mg õhukese polümeerikattega tablett

krka, d.d., novo mesto - finasteriid - õhukese polümeerikattega tablett - 5mg 50tk; 5mg 49tk; 5mg 30tk; 5mg 14tk; 5mg 300tk; 5mg 60tk; 5mg 10tk; 5mg 100tk; 5mg 7tk; 5mg 90tk; 5mg 98tk

FINASTERIDE AUROBINDO õhukese polümeerikattega tablett เอสโตเนีย - เอสโตเนีย - Ravimiamet

finasteride aurobindo õhukese polümeerikattega tablett

aurobindo pharma limited - finasteriid - õhukese polümeerikattega tablett - 5mg 30tk; 5mg 15tk; 5mg 20tk; 5mg 10tk; 5mg 120tk; 5mg 60tk; 5mg 50tk; 5mg 100tk; 5mg 28tk

FINASTERIDE PORTFARMA 5MG õhukese polümeerikattega tablett เอสโตเนีย - เอสโตเนีย - Ravimiamet

finasteride portfarma 5mg õhukese polümeerikattega tablett

portfarma ehf. - finasteriid - õhukese polümeerikattega tablett - 5mg 30tk; 5mg 98tk; 5mg 15tk; 5mg 28tk